Merchav S, Apte R N, Tatarsky I, Ber R
Department of Hematology, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa.
Exp Hematol. 1987 Oct;15(9):995-1000.
Mice bearing syngeneic plasma cell tumors are characterized by elevated numbers of granulocyte-macrophage progenitors (GM-CFU) in the spleen. We investigated the role of syngeneic plasmacytomas in the hematologic response to tumor cell transplantation by assaying the production of granulocyte-macrophage colony-stimulating activity (GM-CSA) by cultured spleen cells of tumor-bearing mice and by plasmacytoma cells, alone and in coculture with spleen cells. Elevated levels of GM-CSA were detected in 7-day culture supernatants of spleen cells from Balb/c mice transplanted 2 weeks previously with syngeneic 4T00.1 plasmacytoma cells. Colony assays of spleen cells from tumor-bearing mice demonstrated the presence of both granulocyte-macrophage and tumor cell colonies. A high frequency of GM-CFU was detected in cultures which had not been supplemented with an exogenous source of GM-CSA. Significant levels of GM-CSA were detected in media conditioned by 4T00.1 plasmacytoma cells. 4T00.1-conditioned medium did not stimulate the growth of primative erythroid (BFU-E) and multilineage (CFU-GEMM) colonies, but stimulated the growth of FDC-P1 cells, thereby establishing the activity produced by 4T00.1 cells as GM-CSF. The levels of GM-CSA in media conditioned by coculturing control spleen and 4T00.1 cells were significantly higher than those detected in media conditioned by spleen cells alone. The colony frequency induced by the coculture supernatants, however, did not exceed the sum of the colonies detected in marrow cell cultures stimulated with media conditioned by control spleen and 4T00.1 cells alone. Our findings demonstrate that murine plasmacytoma cells are capable of secreting GM-CSF. They further suggest a key role for GM-CSA production by tumor cells in the hemopoietic response of mice bearing syngeneic plasma cell tumors.
携带同基因浆细胞瘤的小鼠脾脏中粒细胞-巨噬细胞祖细胞(GM-CFU)数量增多。我们通过检测荷瘤小鼠培养的脾细胞以及浆细胞瘤细胞单独培养和与脾细胞共培养时粒细胞-巨噬细胞集落刺激活性(GM-CSA)的产生,研究了同基因浆细胞瘤在肿瘤细胞移植血液学反应中的作用。在2周前移植了同基因4T00.1浆细胞瘤细胞的Balb/c小鼠脾细胞的7天培养上清液中检测到GM-CSA水平升高。对荷瘤小鼠脾细胞进行集落测定,发现存在粒细胞-巨噬细胞集落和肿瘤细胞集落。在未添加外源性GM-CSA的培养物中检测到高频率的GM-CFU。在4T00.1浆细胞瘤细胞条件培养基中检测到显著水平的GM-CSA。4T00.1条件培养基不刺激原始红系(BFU-E)和多系(CFU-GEMM)集落的生长,但刺激FDC-P1细胞的生长,从而确定4T00.1细胞产生的活性为GM-CSF。对照脾细胞与4T00.1细胞共培养条件培养基中的GM-CSA水平显著高于单独脾细胞条件培养基中检测到的水平。然而,共培养上清液诱导的集落频率不超过用对照脾细胞和4T00.1细胞单独条件培养基刺激的骨髓细胞培养物中检测到的集落总和。我们的研究结果表明,鼠浆细胞瘤细胞能够分泌GM-CSF。它们进一步表明肿瘤细胞产生的GM-CSA在携带同基因浆细胞瘤小鼠的造血反应中起关键作用。